MAGE-A4 TCR gene-modified T cells

MAGE-A4 TCR-engineered T cells · Tianjin Medical University Cancer Institute and Hospital

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MAGE-A4 TCR gene-modified T cells, covering 2015-12-22 to 2015-12-22. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Safety and Preliminary Efficacy of MAGE-A4 TCR Gene-Modified T Cells to Treat Malignant Tumors [Phase 1]